Summary. The clinical and immunological findings are described in a female newborn infant who presented with hypoglycemia associated with a high titre of an insulin-binding protein in her serum. The insulin-binding protein belonged to IgG, the light chain of which consisted solely of Kappa-type. The other properties of the insulinbinding protein were very similar to those of insulin antibodies produced by insulin injection, except for a stronger affinity to human insulin as compared with bovine insulin. The patient's mother had a similar protein in her serum despite no previous history of insulin treatment. It is assumed that, the hypoglycemia of this patient might have been due to the presence of the antibody produced in her mother's body against endogenous insulin and transferred to the patient transplacentally.
Many types of hypoglycemia in newborn infants have been described, but the aetiology of hypoglycemia in some patients is still unknowns.
t{eeently, a female baby born in our hospital showed hypoglycemia shortly after birth and despite thorough studies, her hypoglycemia did not belong to the types of hypoglycemia already known.
Clinical Course
A female baby was born by normal delivery at full term (on August 3, 1971 ) in our hospital. Bh'th weight was 3459 g. She showed a tremor of the extremities three days after birth and at that time her blood sugar was 38 mg/100 ml with Hoffman's method and her Further studies of her insulin dynamics revealed that her serum contained a large amount of an insulinbinding protein, despite no previous history of insulin injection of her or her mother.
In this report, the clinical course and the nature of the insulin-binding substances are described. serum calcimn level was 10.2 rag/100 ml. After that, tremor with hypoglycemia was frequently observed in the fasting state and disappeared with artificial feeding. Eleetroencephalography performed at intervals was normal.
The results of the oral glucose tolerance test ( Bound insulin/Free insulin.
The liver function tests and the hemogram were normal. The plasma cortisol levels were 1.5 ~g/100 ml and 26.2 ug/100 ml before and 1 h after the intramuscular injection of synthetic ACTH (50 ~g/kg). Her immunoglobulin consisted of 730 mg/100 ml of IgG, 75 rag/100 ml of IgM and 20 mg/100 ml of IgA.
The serum immunoreaetive insulin (IgI) levels, estimated by the Morgan-Lazarow two antibody method [2] were markedly high fasting and after food (Fig.  1) . Her serum showed a high titre of insulin-binding activity and contained a large amount of extractable insulin ( Table 1) . The patient's mother, aged 25 years, has had no specific signs or symptoms, but showed a diabetic curve in the oral glucose tolerance test (Fig. 2) . Her serum contained a large amount of insulin-binding substance and extractable insulin (Table 1) , but no rheumatic factor, thyroglobnlin antibody, thyroid mierosomM antibody nor anti-nuclear factor; her serum immunoglobulin consisted of 2350 mg/100 ml of IgG, 112 mg/ 100 ml of IgM and 272 mg/100 ml of IgA.
The baby's hypoglycemia was alleviated, but not completely prevented, with multiple artificial feeding. On December 9, 1971 , prednisolone therapy was initi-ated and the hypoglycemia completely subsided. After a gradual decrease of pI~dnisotone, therapy was suspended on January 10, 1972, without return of the hypoglycaemia.
The insulin-binding substance and the extractable insulin in the baby's serum decreased gradually and her growth was completely normal in the observed period. In contrast to tile baby, the mother's serum insulin-binding substance and the extractable ir~sulin have remained at high levels with only slight fluctuations Table 1 ).
Elution was performed with 0.1 M phosphate buffer (pH 7.4) at 4~ and radioaetivities of every 2 ml fraction of eluate were determined.
Radioeleetrophoresis was performed according to the agarose eleetrophoretie method of Deckert [~] . A mixture of 0,02 ml of serum, 0.01 ml of 125-I-insulin solution (total amount; ca. 160 ~xU.) and 0.02 ml of veronal buffer (pH 8.6, 0.05 M) was incubated over. night at 4~ and a portion of the mixture was applied on agarose gel electrophoresis.
Radioimmunoeleetrophoresis according to the meth- O.02M pH Z4 RB. Number of Tube (SN 72-2) Fig. 3 . The Sephadex G-J00 column chromatography of the mixture of the baby's (left side) or the mother's (right side) serum, radioinsulin and 0.02M phosphate buffer (pH 7.4) containing 0.5% bovine serum albumin. The white column indicates the radioactivity and black column indicates protein content in 2 ml of fractions. The eluting solution is described in the right, side of each figure
Experimental Methods
Titre of the insulin binding substance was determined with the Sephadex chromatographic method of Horiuchi et el. [3] and expressed in values of B/F. The mixture containing 0.2 ml of serum, 0.1 ml of 125-Iinsulin solution (total amount; ca. 4 b~lJ.) and 0,7 ml of 0.1 M phosphate buffer (ptI 7.4) containing 0.5% bovine serum albumin was incubated at 4~ for 3 days and applied on a Sephadex G-100 column (1.0 • 15 em).
od of u and Meier [5] and specific immunoprecipitation were performed with antisera purchased from Beringwerke AG. Marburg, Lahn, Germany.
The autoradiography was performed by contact of slides with a medical X-ray film (Type Kx, Fuji Photo Industries Co., Tokyo, Japan) for 3 weeks.
Determination of serum free and total h~sulin levels was performed by radioimmunoassay after extraction by polyethyIene glycol solutior~ [6] .
125-I-insulin with a high specific activity (150--300 mCi/mg) was obtained from Abbott Laboratories, Oak Ridge, Tenn. U.S.A. and purified by the method of Banerzee (7) . The blood sugar was determined by Hoffman's method on an Auto-Analyzer.
Experimental Results

Sephadex G 100 Column Chromatography
When elated with 0.02 M phosphate buffer after the incubation and the application on the Sephadex column of mother's or baby's serum, as described in experi-
Radioelectrophore~i8
With radioelectrophoresis of the mother's serum, all radioactivity was found in the gamma-globulin fraetion. In the case of the baby's serum, most of the radioactivity was found in the gamma-globulin fraction and a small amount of the radioactivity in the alphaglobulin fraction (free insulin fraction). Also, in this test when a large amount of cold insulin (total amount : 100 mU.) was added to the incubation mixture, most of the radioactivity was found in the alphad-globulin fraction (Fig. 4) . 9 These results indicate that the insulin-binding substance in their sera was contained in gamma-globulin. mental method, most of the radioinsulin was eluted in the protein fractions and some part in the free insulin fractions. With 0.1 5{ glyeine-ttC1 buffer (pH 3.0) as t h e eluent, most of the radioinsulin was elnted in the free insulin fractions. When a large amount of cold porcine insulin (total amount ca. 12 mU.) was added in the incubation mixture, most of the radioinsulin was eluted in the free insulin fractions (Fig. 3) . These results indicate that the binding substance in their sera was a high molecular substance which bound specifically to insulin and dissociated at a low pH.
Radioimmunoelectrophore.si8
Radioimmunoetectrophoresis of the baby's and mother's sera against rabbit anti-whole human serum, anti-human IgG, anti-human IgM, anti-human IgA and anti-human IgD were performed. Precipitation lines were obtained except in IgD of the baby and the mother and IgA of the baby, but radioactivity of the precipitation line was detected only in IgG of mother and baby (Fig. 5) .
This result indicates that the insulin-binding substance in their sera was contained in IgG.
Production of the Insulin-Binding Substance by Periphe~'al Lymphocytes in Vitro
The iymphoeytes separated from 20 ml of the mother's peripheral blood were cultured in vitro at 38 ~ C for 5 days, according to the method of Miyai et al. [8] .
The supernatant of the culture was incubated with radioinsulin and the insulin-binding activity was determined ~4th the same method as in the sera. The insulin-binding substance was detected in the supernatant of the culture of the mother's lymphocytes and concentration with dialysis against 0.1 M phosphate buffer (pI-I 7.4) containing 20% gum arabic. The insulin-free serum was incubated with a constant amount of porcine radioinsulin (total amount; ca. 4 uU.) and various amount of cold insulins from human, porcine, bovine, bonito and tuna pancreas. After the incubation, the binding of the radioinsulin was determined with the Sephadex column chromatography.
tIuman and porcine insulins were bound more strongly than bovine insulin to the insulin-binding substance. Tuna and Bonito insulins cross-reacted less Radioimmu noe[ect rophoresis The antiserum used is indicated in the right side of the figure with or without phytohemoagglutinin, but not in that of the control patient and the binding was dissociated with the addition of large amount of cold insulin (total amount: 12 mU.) ( Table 2 ). The binding substance was also shown by agarose gel electrophoresis.
The Affinity of the Insulin-Binding Substance to Various Species of Insulin
The insulin-free sera of the mother and the baby were obtained by separation in Scphadex G-100 column chromatography (0.1 M glycine-HC1 buffer, pl-[ 3.0) strongIy than did any of human, porcine and bovine insulin (Table 3) .
Heavy Chain of the Insulin-Binding Substance
As described above, by radioimmunoelectrophoresis, the binding substance was contained only in IgG. For further confirmation, radioimmunodiffusion using a larger amount of serum (10 ~l.) against anti-human IgG, anti-human IglV[ and anti-human IgA serum, with a similar technique to radioimmunoelectrophoresis, was performed. As shown in Table 4 , in the baby's and the mother's sera neither IgM nor IgA antibody was detected in contrast to that in sera from insulintreated patients with comparable titres of antibodies. IgM antibody was detected in all sera and IgA antibody in some sera (Table 4) .
Light Chain of the Insulin-Binding Substance
As shown in Fig. 5 in radioimmunoelectrophoresis, no radioactivity was detected in IgG-lambda-chain precipitate. For further confirmation, a specific precipitation test was performed. After the incubation of 0.2 ml of the mother's or baby's serum with 0.01 ml of cipitate was higher as compared to the ratio of the lambda-chain precipitate and the ratio of the latter was equivalent to that of the control serum, the radioactivity of which was caused by non-specific co-precipitation of radioinsulin.
The result showed that the insulin-binding substance in the mother's and the baby's sera had pure IgG-Kappa-chain.
Dilution Test of Serum Extractable Insulin
The extracted insulin from the baby's or the mother's serum with the polyethylene glycol method was radioinsulin solution (total amount ca. 4 ~U.) at 4~ for 3 days, rabbit anti-kappa-chain or anti-lambdachain serum containing an approximately equivalent amount of antibody was added. After overnight incubation, the precipitate was washed thoroughly with a buffered saline solution, then the radioactivity and the protein in the precipitate was determined (Table   5 ).
In the serum from an insulin-treated patient, the ratio of radioactivity to the protein in the kappa-chain precipitation was substantially the same as that in the lambda-chain precipitate, but in the serum from the mother or the baby, the ratio in the kappa-chain prediluted serially and the insulin in the diluted solution was determined with the radioimmunoassay. The insulin levels calculated with human insulin as standard were inversely proportional to the dilution factors (Fig.   7 ).
Insulin Degradation Test
The extracted insulin from the mother's serum with the polyethylene glycol method was subjected to the degradation test of Elliott et al. [9, 10] with the insulinspecific peptidase from rat skeletal muscle.
The ratio of degradation was not different from that of the standard human insulin (Table 6 ).
Discussion
The insulin-binding protein in the sera of both baby and mother had the same characteristics on Sephadex chromatography, agarose gel electrophoresis and radioimmunoeleetrophoresis as insulin-antibodies from insulin-treated diabetics and was produced by the mother's peripheral lymphocytes in vitro. These findings indicate that the substance is an insulin antibody although no previous insulin treatment had been administered to these patients. Antibody titre was determined with the method described in the text.
All radioimmmmdiffusion was performed at the same time in the same conditions. hypothesis that this insulin antibody was not produced against exogenous insulins, but produced probably against endogenous insulin.
The first evidence is that the insulin antibody has a simple immunoglobulin type (IgG-Kappa) which was not found in thirty eases of insulin-treated diabetics in our experience. Only one case of an insulin-treated diabetic with an insulin-antibody consisting of a single immunoglobulin type (IgG-Lambda) has been reported, Simple denial by the patient does not rule out previous insulin injections, as pointed out by Berkowitz et al. [11] , but in this ease, no reason for insulin therapy existed and the mother's abnormality of GTT was found after the baby's disease was recognized. In addition, two further pieces of evidence support the by Faulk et al. [12] , but the associated haemolytie anaemia, splenomegaly and hepatomegaly suggested that the patient had disturbances of the antibody producing mechanism.
The second evidence is that this antibody had a stronger affinity to human insulin and porcine insulin than with bovine insulin. In this country, no pure porcine intermediately acting insulin preparation has been available and pure bovine or bovine-porcine intermediately acting insulin preparations have been used for treatment of diabetes. Insulin antibodies produced by these preparations had stronger affinities to bovine insulin without exception in our studies.
In the observed period, a gradual decrease of the baby's antibody titre ensued, but the mother's elevated antibody titre was retained. The clearance rate of the baby's antibody titre was approximately coincident, to the clearance rate of mother's IgG from baby's serum after bit~.h reported by Stiehm and Fudenberg [13] and not infuenced by the administration of glucocorticoids. Thorell and Joergensen reported that the IgG insulin antibody transferred easily into foetal serum [14, 15] . These considerations, in addition to the fact that the baby's antibody had the same properties as the mother's antibody, make it highly probable that the baby's antibody was transferred transplacentally from the mother's serunl.
There are two possibilities with regard to the mechanism by which this mother produced the insulin antibody against her endogenous insulin.
One possibility is the acquisition of antigenicity of her endogenous insulin by some kind of denaturation and cross-reaction of the antibody to her non-denatured endogenous insulin. This is supported by the experimental facts that homologous insulins are made antigenic by acid ethanol treatment and the induced antibodies cross-react with non-denatured, endogenous insulin [16, 17, 18] . The occurrence of such a minor denaturation might occur in the human body. In the dilution test and the degradation test, no abnormality of the mother's serum insulin was found, but a minor denaturation or minor part of denaturation which might be undeteetable by such test, could cause the antibody production.
The other possibility is production of antibody by changing antibody-producing mechanisms. This seems to be supported by the fact that the antibody consisted of a monoeomponent immunoglobulin, but against this, no other autoantibody could be detected in this patient. In addition, Nussenzeig et al. [19] , Herd and Cebra [20] , and Yamashita et al. [21] reported experimental produetion of antibodies with a single light chain against haptens after a Iong immunization. Therefore, the monocomponent antibody in this mother might be explained by immunization by her denatured endogenous insulin for a long period.
In this baby, no factor causing hypoglyeaemia was found except for the presence of a large amount of insulin antibody and extractable insulin in her serum. l-Iirata et al. [22, 23, 24] and Folling and Norman [25] reported adult cases of hypoglycaemia with high titres of insulin antibody and large amounts of extractable insulin in their sera, but there was no previous history of insulin injection in their patients. In addition, Hirata et al. [23] reported the occurrence of hypoglyeaemia in some animals immunized with insulin, even after the termination of insulin injection. He postulated that the hypoglycemia was due to the presence of a large amount of inactive bound insulin and an occasional increase in active free insulin in serum by dissociation of the bound insulin. This explanation is applicable to this ease.
The reason why the mother showed no hypoglycaemia despite a large amount of antibody could be explained in two ways.
The first hypothesis is that the mother's antibody is not completely saturated with endogenous insulin due to extlausted islet function produced by overactivity for a long period, so an increase in free insulin level hardly occurs. The second hypothesis is that aduIts are more resistant to hyperinsulinism due to more accomplished glueoneogenetic mechanisms, an hypothesis invoked in the pathogenesis of idiopathic neonatal hypoglycaemia [26] . In this patient, however, no confirmatory data to support either hypothesis was obtained, so further investigations are required to clarify the mechanism of hypoglycaemia.
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